Important Information
This website uses cookies. By using this website you accept the use of cookies. Learn more.
RTPR has advised private equity funds Morphosis Capital and Integral Capital Group on their exit from Medima through its strategic sale to Simago, one of Europe’s leading consolidators in the medical imaging sector, backed by Ardian, in its first investment in Central and Eastern Europe. Medima Health is a Romanian medical-imaging group operating 34 clinics in 30 cities across the country. The transaction also marked the full exit of Professor Dr. Gheorghe Iana, Medima’s co-founder, while co-founder and CEO Vlad Ardeleanu rolled over his entire stake, remaining a shareholder alongside Simago.
The RTPR team of lawyers was coordinated by Partners Costin Taracila and Alina Stavaru.
“This has been a highly complex transaction, with multiple stakeholders and multiple interests that had to be aligned. The RTPR team played not only a technical role but a truly active role in the deal dynamic, helping all parties find common ground and actively managing complex human dynamics. This is what sets them apart as not just a legal advisor but as a true deal partner!”, said Andrei Gemeneanu, Managing Partner at Morphosis Capital.
“What impressed us most about RTPR was their ability to keep a complicated deal moving forward. With so many parties, advisers and different interests involved, there were plenty of challenges along the way. The team knew when to push, when to find common ground and how to manage strong personalities without losing sight of our objectives. Their experience and commercial instinct made a real difference”, said Radu Constantin, Investment Director at Integral Capital Group.
“Long-standing client relationships are among the most rewarding aspects of our work. We have advised both Morphosis Capital and Integral Capital Group on multiple investments, including Integral’s entry into Medima in 2022. Supporting our clients from investment to exit makes this deal particularly special. Medima is a great example of what private equity, entrepreneurial vision and medical expertise can achieve together. We congratulate everyone involved and thank our clients for their continued trust”, said Costin Taracila, Managing Partner of RTPR.
“A successful exit is not just about reaching an agreement, but about making every piece of the transaction fit. With multiple parties around the table, this requires careful coordination and a clear understanding of how individual legal decisions affect the final outcome. Our role was to bring clarity to that complexity, protect our clients’ interests and keep the transaction moving towards a shared finish line. We are delighted to have stood alongside Morphosis Capital and Integral Capital Group at this defining moment and thank them for their trust”, said Alina Stavaru, Partner at RTPR.
The mandate continues RTPR’s relationship with both investors. Most recently, the law firm announced the closing of another project in which it advised Morphosis Capital on its investment in Umana Fertility and Royal Hospital to create PRIMIA MEDICAL, a healthcare network dedicated exclusively to women. Further collaborations include advice on the fund’s other investments in Romania, such as Mark Twain International School, a private, international school, accredited by the International Baccalaureate, as well as by the Romanian Ministry of Education (2024), EMI Equipement Maintenance Industrie S.A., a market leader in industrial access systems (2021), Cronos Med Group, a leader in aesthetic medicine (2021).
RTPR also advised Integral Capital Group on its acquisition of a majority stake in Embryos, a Romanian fertility and gynaecology clinic (2025), as well as its investment in Medima Health in 2022.
RTPR is well-known for its extensive experience in transactions involving investment funds, during the last few years it was involved in most of the private equity deals in Romania, both on buy-side and sell-side mandates, as well as advising their portfolio companies on bolt-on acquisitions. The firm’s unrivalled expertise in the largest and most interesting transactions in Romania and in the region has been recognised by the leading international legal directories, such as Chambers & Partners, Legal 500 and IFLR1000, which rank RTPR’s Corporate/M&A practice on the first tier. At the same time several team members are recommended as Leading Lawyers or Rising Stars in this area.
Selected deals in which RTPR have recently advised funds are set out below: